drugset / Trial / NCT06515938

Study on New Strategies for Hepatitis B Virus Immunization

NCT06515938

Completed 1169 enrolled Wu Jiang
RandomizedParallel-groupOpen-labelPrevention

Summary

To investigate the immunogenicity of HB vaccine with different series among primary immune adults aged 25-55, to assess potential alternative approaches for HB immunization.

Timeline

Start
2013-01-01
Primary completion
2014-06-30
Completion
2015-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Engerix-B Vaccine 20 ug Intramuscular
Comparator Huabei Vaccine 20 ug Intramuscular
Subject Kangtai Vaccine 20 ug Intramuscular
Subject Kangtai Vaccine 60 ug Intramuscular

Indications